Related Experiment Video
Updated: Jan 14, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Health Benefits In 2025: Family Premiums Rise 6 Percent, Large Employers Increase Coverage Of GLP-1s For Weight Loss
Gary Claxton1, Matthew Rae2, Anthony Damico3
1Gary Claxton, KFF, Washington, D.C.
Abstract:
In 2025, the average annual premium for family health coverage reached $26,993, an increase of $1,408 (6 percent) from the previous year. Covered workers contributed an average of 16 percent ($1,440) toward premiums to enroll in single coverage and 26 percent ($6,850) for family coverage. Among workers with a general annual deductible for single coverage, the average deductible was $1,886. Nearly one in five (19 percent) large firms offering health benefits covered GLP-1 agonists when used primarily for weight loss. Many employers reported concern about out-of-pocket spending: 45 percent of firms offering health benefits indicated that their employees had a "high" or "moderate" level of concern about the affordability of cost sharing. Thirty-six percent of large firms offering health benefits reported that prescription drug prices contributed "a great deal" toward premium increases.
More Related Videos
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
03:05Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study
Published on: November 21, 2025
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: Glinides
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity